The systemic hormonal preparations market in Italy, excluding sex hormones and insulins, is projected to grow steadily from 2024 to 2028. Beginning at 826.1 million US dollars (PPP) in 2024, the forecast indicates a consistent upward trend reaching 863.8 million US dollars by 2028. This growth suggests a compound annual growth rate (CAGR) of approximately 1.1% over this five-year period. As of 2023, the market stood at an actual value slightly below the 2024 starting point, reflecting this continued positive momentum.

Future trends to watch for include:

Technological advancements in hormone delivery systems driving innovation.
Growing awareness and diagnosis of hormonal disorders increasing market demand.
Policy changes in the healthcare sector potentially impacting market access and pricing.
Research breakthroughs influencing new product development and market expansion.